Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia

NCT06429449 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT06429449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06429449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia
Lead sponsor
University of Colorado, Denver
Phase
Phase 1
Overall status
Recruiting
Start date
July 21, 2024
Completion date
November 30, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, monocytic leukemia, myeloid leukemia